Clinical Trial

Diffrence in Thromboprofilaksis in Elderly Ostoepenic Hip Fractures According to Mobility Status by Genetic Analysis

Study acronym: HSP 47
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Hip fracture is a common and severe disease in elderly patients. The question of the study is whether elderly patients with severe osteopenia have significantly lower levels of the collagen-binding protein Hsp47 than relatively mobile patients due to advanced immobility before the fracture, and whether they participants have a similar risk of VTE to the normal population despite having had a hip fracture and surgery.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-26; most recent amendment 2025-06-02.
Status change: Recruiting → Active, Not Recruiting 2025-06-02
Trial Details
NCT Number NCT06959017
Lead Sponsor Saglik Bilimleri Universitesi
Conditions Hip Fracture of Intertrochanteric Type, Thromboembolic Event, Osteopenia, Thrombosis Embolism
Enrollment 90 participants
Start Date 2024-11-01
Primary Completion 2025-06-01 (estimated)
Study Completion 2025-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-05